- Home
- ITCI vs DLB Comparison
ITCI vs DLB Comparison
Compare ITCI & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- DLB
- Stock Information
- Founded
- ITCI 2002
- DLB 1965
- Country
- ITCI United States
- DLB United States
- Employees
- ITCI N/A
- DLB N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- DLB Multi-Sector Companies
- Sector
- ITCI Health Care
- DLB Miscellaneous
- Exchange
- ITCI Nasdaq
- DLB Nasdaq
- Market Cap
- ITCI 8.0B
- DLB 7.1B
- IPO Year
- ITCI N/A
- DLB 2005
- Fundamental
- Price
- ITCI $76.91
- DLB $73.46
- Analyst Decision
- ITCI Strong Buy
- DLB Strong Buy
- Analyst Count
- ITCI 12
- DLB 3
- Target Price
- ITCI $97.00
- DLB $98.67
- AVG Volume (30 Days)
- ITCI 438.6K
- DLB 316.6K
- Earning Date
- ITCI 10-30-2024
- DLB 11-19-2024
- Dividend Yield
- ITCI N/A
- DLB 1.63%
- EPS Growth
- ITCI N/A
- DLB N/A
- EPS
- ITCI N/A
- DLB 2.18
- Revenue
- ITCI $564,526,000.00
- DLB $1,259,477,000.00
- Revenue This Year
- ITCI $46.60
- DLB N/A
- Revenue Next Year
- ITCI $37.06
- DLB $4.50
- P/E Ratio
- ITCI N/A
- DLB $33.69
- Revenue Growth
- ITCI 54.31
- DLB N/A
- 52 Week Low
- ITCI $45.50
- DLB $66.35
- 52 Week High
- ITCI $84.89
- DLB $90.06
- Technical
- Relative Strength Index (RSI)
- ITCI 57.52
- DLB 49.77
- Support Level
- ITCI $71.95
- DLB $72.96
- Resistance Level
- ITCI $79.46
- DLB $74.84
- Average True Range (ATR)
- ITCI 1.79
- DLB 1.03
- MACD
- ITCI 0.49
- DLB -0.15
- Stochastic Oscillator
- ITCI 70.25
- DLB 26.38
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.